Financhill
Buy
64

BRO Quote, Financials, Valuation and Earnings

Last price:
$113.39
Seasonality move :
2.68%
Day range:
$111.02 - $113.23
52-week range:
$87.88 - $125.68
Dividend yield:
0.51%
P/E ratio:
31.45x
P/S ratio:
6.68x
P/B ratio:
4.74x
Volume:
1.9M
Avg. volume:
1.7M
1-year change:
28.66%
Market cap:
$32.4B
Revenue:
$4.7B
EPS (TTM):
$3.59

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BRO
Brown & Brown
$1.4B $1.30 10.59% 10.78% $118.51
AJG
Arthur J. Gallagher &
$3.7B $3.58 15.87% 89% $338.73
CRVL
CorVel
-- -- -- -- --
EHTH
eHealth
$99.5M -$0.43 -30.18% -6.02% $10.00
KINS
Kingstone Companies
$41.7M -- 22.19% 48.65% $22.00
MMC
Marsh & McLennan Companies
$7.1B $3.00 11.23% 17.75% $233.22
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BRO
Brown & Brown
$112.90 $118.51 $32.4B 31.45x $0.15 0.51% 6.68x
AJG
Arthur J. Gallagher &
$345.91 $338.73 $88.6B 53.22x $0.65 0.71% 6.74x
CRVL
CorVel
$111.27 -- $5.7B 60.58x $0.00 0% 6.46x
EHTH
eHealth
$4.10 $10.00 $124.3M -- $0.00 0% 0.22x
KINS
Kingstone Companies
$16.30 $22.00 $228.3M 10.25x $0.00 0% 1.25x
MMC
Marsh & McLennan Companies
$233.66 $233.22 $115.1B 28.63x $0.82 1.4% 4.63x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BRO
Brown & Brown
35.81% 0.365 10.67% 0.68x
AJG
Arthur J. Gallagher &
36.96% 0.855 14.8% 0.57x
CRVL
CorVel
-- 1.561 -- 1.35x
EHTH
eHealth
6.89% -1.613 12.54% 2.49x
KINS
Kingstone Companies
6.13% 2.322 2.34% 28.29x
MMC
Marsh & McLennan Companies
59.34% 0.514 17.38% 0.48x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BRO
Brown & Brown
$702M $452M 10.16% 16.34% 34.3% $196M
AJG
Arthur J. Gallagher &
$1.8B $1B 6.05% 10.03% 27.66% $843.6M
CRVL
CorVel
$58.2M $33.3M 33.58% 33.58% 14.39% $14.3M
EHTH
eHealth
$313.9M $4.8M 3.8% 4.17% 5.64% $73.7M
KINS
Kingstone Companies
-- -- 28.17% 36.5% 9.79% $17M
MMC
Marsh & McLennan Companies
$3.2B $2B 13.63% 29.77% 29.34% -$677M

Brown & Brown vs. Competitors

  • Which has Higher Returns BRO or AJG?

    Arthur J. Gallagher & has a net margin of 23.9% compared to Brown & Brown's net margin of 18.9%. Brown & Brown's return on equity of 16.34% beat Arthur J. Gallagher &'s return on equity of 10.03%.

    Company Gross Margin Earnings Per Share Invested Capital
    BRO
    Brown & Brown
    50.69% $1.15 $10.6B
    AJG
    Arthur J. Gallagher &
    48.04% $2.72 $35.4B
  • What do Analysts Say About BRO or AJG?

    Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 4.97%. On the other hand Arthur J. Gallagher & has an analysts' consensus of $338.73 which suggests that it could fall by -2.88%. Given that Brown & Brown has higher upside potential than Arthur J. Gallagher &, analysts believe Brown & Brown is more attractive than Arthur J. Gallagher &.

    Company Buy Ratings Hold Ratings Sell Ratings
    BRO
    Brown & Brown
    3 7 0
    AJG
    Arthur J. Gallagher &
    6 7 0
  • Is BRO or AJG More Risky?

    Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison Arthur J. Gallagher & has a beta of 0.745, suggesting its less volatile than the S&P 500 by 25.514%.

  • Which is a Better Dividend Stock BRO or AJG?

    Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.51%. Arthur J. Gallagher & offers a yield of 0.71% to investors and pays a quarterly dividend of $0.65 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Arthur J. Gallagher & pays out 35.92% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BRO or AJG?

    Brown & Brown quarterly revenues are $1.4B, which are smaller than Arthur J. Gallagher & quarterly revenues of $3.7B. Brown & Brown's net income of $331M is lower than Arthur J. Gallagher &'s net income of $704.4M. Notably, Brown & Brown's price-to-earnings ratio is 31.45x while Arthur J. Gallagher &'s PE ratio is 53.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.68x versus 6.74x for Arthur J. Gallagher &. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BRO
    Brown & Brown
    6.68x 31.45x $1.4B $331M
    AJG
    Arthur J. Gallagher &
    6.74x 53.22x $3.7B $704.4M
  • Which has Higher Returns BRO or CRVL?

    CorVel has a net margin of 23.9% compared to Brown & Brown's net margin of 11.41%. Brown & Brown's return on equity of 16.34% beat CorVel's return on equity of 33.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    BRO
    Brown & Brown
    50.69% $1.15 $10.6B
    CRVL
    CorVel
    25.13% $0.51 $322M
  • What do Analysts Say About BRO or CRVL?

    Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 4.97%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Brown & Brown has higher upside potential than CorVel, analysts believe Brown & Brown is more attractive than CorVel.

    Company Buy Ratings Hold Ratings Sell Ratings
    BRO
    Brown & Brown
    3 7 0
    CRVL
    CorVel
    0 0 0
  • Is BRO or CRVL More Risky?

    Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison CorVel has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.958%.

  • Which is a Better Dividend Stock BRO or CRVL?

    Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.51%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BRO or CRVL?

    Brown & Brown quarterly revenues are $1.4B, which are larger than CorVel quarterly revenues of $231.5M. Brown & Brown's net income of $331M is higher than CorVel's net income of $26.4M. Notably, Brown & Brown's price-to-earnings ratio is 31.45x while CorVel's PE ratio is 60.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.68x versus 6.46x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BRO
    Brown & Brown
    6.68x 31.45x $1.4B $331M
    CRVL
    CorVel
    6.46x 60.58x $231.5M $26.4M
  • Which has Higher Returns BRO or EHTH?

    eHealth has a net margin of 23.9% compared to Brown & Brown's net margin of 1.72%. Brown & Brown's return on equity of 16.34% beat eHealth's return on equity of 4.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    BRO
    Brown & Brown
    50.69% $1.15 $10.6B
    EHTH
    eHealth
    99.6% -$0.33 $998.4M
  • What do Analysts Say About BRO or EHTH?

    Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 4.97%. On the other hand eHealth has an analysts' consensus of $10.00 which suggests that it could grow by 143.9%. Given that eHealth has higher upside potential than Brown & Brown, analysts believe eHealth is more attractive than Brown & Brown.

    Company Buy Ratings Hold Ratings Sell Ratings
    BRO
    Brown & Brown
    3 7 0
    EHTH
    eHealth
    1 4 0
  • Is BRO or EHTH More Risky?

    Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison eHealth has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.531%.

  • Which is a Better Dividend Stock BRO or EHTH?

    Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.51%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BRO or EHTH?

    Brown & Brown quarterly revenues are $1.4B, which are larger than eHealth quarterly revenues of $113.1M. Brown & Brown's net income of $331M is higher than eHealth's net income of $2M. Notably, Brown & Brown's price-to-earnings ratio is 31.45x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.68x versus 0.22x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BRO
    Brown & Brown
    6.68x 31.45x $1.4B $331M
    EHTH
    eHealth
    0.22x -- $113.1M $2M
  • Which has Higher Returns BRO or KINS?

    Kingstone Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 7.69%. Brown & Brown's return on equity of 16.34% beat Kingstone Companies's return on equity of 36.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    BRO
    Brown & Brown
    50.69% $1.15 $10.6B
    KINS
    Kingstone Companies
    -- $0.27 $87.6M
  • What do Analysts Say About BRO or KINS?

    Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 4.97%. On the other hand Kingstone Companies has an analysts' consensus of $22.00 which suggests that it could grow by 34.97%. Given that Kingstone Companies has higher upside potential than Brown & Brown, analysts believe Kingstone Companies is more attractive than Brown & Brown.

    Company Buy Ratings Hold Ratings Sell Ratings
    BRO
    Brown & Brown
    3 7 0
    KINS
    Kingstone Companies
    1 0 0
  • Is BRO or KINS More Risky?

    Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.731%.

  • Which is a Better Dividend Stock BRO or KINS?

    Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.51%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Brown & Brown's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BRO or KINS?

    Brown & Brown quarterly revenues are $1.4B, which are larger than Kingstone Companies quarterly revenues of $50.5M. Brown & Brown's net income of $331M is higher than Kingstone Companies's net income of $3.9M. Notably, Brown & Brown's price-to-earnings ratio is 31.45x while Kingstone Companies's PE ratio is 10.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.68x versus 1.25x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BRO
    Brown & Brown
    6.68x 31.45x $1.4B $331M
    KINS
    Kingstone Companies
    1.25x 10.25x $50.5M $3.9M
  • Which has Higher Returns BRO or MMC?

    Marsh & McLennan Companies has a net margin of 23.9% compared to Brown & Brown's net margin of 19.56%. Brown & Brown's return on equity of 16.34% beat Marsh & McLennan Companies's return on equity of 29.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    BRO
    Brown & Brown
    50.69% $1.15 $10.6B
    MMC
    Marsh & McLennan Companies
    45.48% $2.79 $34.8B
  • What do Analysts Say About BRO or MMC?

    Brown & Brown has a consensus price target of $118.51, signalling upside risk potential of 4.97%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $233.22 which suggests that it could fall by -0.26%. Given that Brown & Brown has higher upside potential than Marsh & McLennan Companies, analysts believe Brown & Brown is more attractive than Marsh & McLennan Companies.

    Company Buy Ratings Hold Ratings Sell Ratings
    BRO
    Brown & Brown
    3 7 0
    MMC
    Marsh & McLennan Companies
    4 12 0
  • Is BRO or MMC More Risky?

    Brown & Brown has a beta of 0.838, which suggesting that the stock is 16.159% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.827, suggesting its less volatile than the S&P 500 by 17.269%.

  • Which is a Better Dividend Stock BRO or MMC?

    Brown & Brown has a quarterly dividend of $0.15 per share corresponding to a yield of 0.51%. Marsh & McLennan Companies offers a yield of 1.4% to investors and pays a quarterly dividend of $0.82 per share. Brown & Brown pays 15.51% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios BRO or MMC?

    Brown & Brown quarterly revenues are $1.4B, which are smaller than Marsh & McLennan Companies quarterly revenues of $7.1B. Brown & Brown's net income of $331M is lower than Marsh & McLennan Companies's net income of $1.4B. Notably, Brown & Brown's price-to-earnings ratio is 31.45x while Marsh & McLennan Companies's PE ratio is 28.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Brown & Brown is 6.68x versus 4.63x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BRO
    Brown & Brown
    6.68x 31.45x $1.4B $331M
    MMC
    Marsh & McLennan Companies
    4.63x 28.63x $7.1B $1.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is IONQ The Next NVIDIA?
Is IONQ The Next NVIDIA?

Quantum computing startup IonQ (NYSE:IONQ) has seen its stock skyrocket…

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for Jun 2

Regeneron Pharmaceuticals [REGN] is up 0.05% over the past day.

Buy
55
RGC alert for Jun 2

Regencell Bioscience Holdings [RGC] is down 19.04% over the past day.

Sell
42
AMBA alert for Jun 2

Ambarella [AMBA] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock